CRH (CRH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved 9% year-over-year revenue growth to $7.4 billion in Q1 2026, driven by strong demand, disciplined execution, and acquisitions.
Adjusted EBITDA rose 18% to $586 million, with margin improving to 8.0% from 7.3% a year ago.
Net loss widened to ($180) million, impacted by a $48 million impairment in International Solutions, higher depreciation, and interest expense.
Announced $1.9 billion in divestitures of non-core businesses and $900 million in nine value-accretive acquisitions, including Axius Water.
Continued significant shareholder returns via $400 million in share buybacks YTD and a 5% increase in quarterly dividend to $0.39 per share.
Financial highlights
Q1 revenues reached $7.4 billion, up 9% year-over-year, supported by strong demand and acquisitions.
Adjusted EBITDA was $586 million, up 18% year-over-year, with margin improving to 8.0% from 7.3% in Q1 2025.
Net loss margin for Q1 2026 was -2.4%, compared to -1.5% prior year.
Gross profit increased 11% to $2.0 billion, with gross margin up 50bps to 27.7%.
Interest expense increased to $203 million, up $22 million year-over-year due to higher debt balances.
Outlook and guidance
Reaffirmed FY26 guidance: Adjusted EBITDA $8.1–$8.5 billion, net income $3.9–$4.1 billion, diluted EPS $5.60–$6.05.
Capital expenditure guidance set at $2.8–$3.0 billion; effective tax rate of 24%.
Guidance assumes normal seasonal weather, no major geopolitical or macroeconomic disruptions, and excludes significant one-off items.
Positive demand outlook across transportation, water, and reindustrialization, with robust backlogs and strong funding support.
Residential new-build remains subdued, but repair and remodel activity is expected to be resilient.
Latest events from CRH
- Strong organic profit growth and cash generation cut year-end net debt below 3x EBITDA.CRH
H2 2015 - Strong growth and cash generation cut leverage to 1.7x while supporting further growth.CRH
H2 2016 - €3.3bn EBITDA, stronger margins and returns, and major acquisitions positioned for further growth.CRH
H2 2017 - U.S. momentum and cost actions supported 2013 progress as net debt fell EUR 519m.CRH
H2 2012 - H2 momentum improved as portfolio actions and disciplined investment set up a moderate 2014 recovery.CRH
H2 2013 - EBITDA rose 11% in 2014; 2015 priorities were growth, integration and debt reduction.CRH
H2 2014 - Sales rose 5% and EBITDA reached €1.66bn as margins proved resilient.CRH
H2 2011 - Cash discipline and cost savings steadied results as markets began to stabilize.CRH
H2 2010 - Q3 EBITDA held near prior year; FY26 guidance is $7.8B–$8.0B amid cost and residential headwinds.CRH
Q3 2026 - Q2 2026 saw strong growth, margin gains, and the Arcosa deal, supporting a positive outlook.CRH
Q2 2026